In the present study, we showed that ITGB6 interacts with the inactive EGFR in NSCLC, whereas in SCLC, ITGB2 reduces the levels of ITGB6, and interacts with and activates EGFR. The gene discussed is ITGB2; the disease is non-small cell lung carcinoma.